TD Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-189,340
| Closed | -$59.9M | – | 1456 |
|
|
2023
Q4 | $59.9M | Sell |
189,340
-38,378
| -17% | -$12.1M | 0.06% | 265 |
|
|
2023
Q3 | $38.5M | Buy |
227,718
+79,291
| +53% | +$13.4M | 0.05% | 300 |
|
|
2023
Q2 | $32.2M | Buy |
148,427
+8,492
| +6% | +$1.84M | 0.04% | 347 |
|
|
2023
Q1 | $25.4M | Buy |
139,935
+39,254
| +39% | +$7.13M | 0.03% | 395 |
|
|
2022
Q4 | $19.8M | Buy |
100,681
+23,900
| +31% | +$4.7M | 0.02% | 434 |
|
|
2022
Q3 | $17.2M | Buy |
76,781
+36,810
| +92% | +$8.26M | 0.02% | 449 |
|
|
2022
Q2 | $5.06M | Sell |
39,971
-6,500
| -14% | -$822K | 0.01% | 769 |
|
|
2022
Q1 | $5.89M | Sell |
46,471
-776
| -2% | -$98.4K | 0.01% | 789 |
|
|
2021
Q4 | $6.19M | Buy |
47,247
+7,337
| +18% | +$961K | 0.01% | 808 |
|
|
2021
Q3 | $4.88M | Buy |
39,910
+1,900
| +5% | +$232K | 0.01% | 822 |
|
|
2021
Q2 | $4.34M | Buy |
38,010
+992
| +3% | +$113K | ﹤0.01% | 866 |
|
|
2021
Q1 | $4.45M | Buy |
37,018
+8,581
| +30% | +$1.03M | 0.01% | 862 |
|
|
2020
Q4 | $2.89M | Hold |
28,437
| – | – | ﹤0.01% | 930 |
|
|
2020
Q3 | $2.2M | Buy |
28,437
+1,500
| +6% | +$116K | ﹤0.01% | 883 |
|
|
2020
Q2 | $3M | Buy |
26,937
+600
| +2% | +$66.9K | ﹤0.01% | 782 |
|
|
2020
Q1 | $1.9M | Sell |
26,337
-400
| -1% | -$28.8K | ﹤0.01% | 849 |
|
|
2019
Q4 | $2.01M | Buy |
26,737
+3,806
| +17% | +$287K | ﹤0.01% | 928 |
|
|
2019
Q3 | $374K | Buy |
+22,931
| New | +$374K | ﹤0.01% | 1222 |
|